Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts.
Arkadiusz Gruchlik, Magdalena Jurzak, Ewa Chodurek, Zofia Dzierzewicz
Index: Acta Pol. Pharm. 69(6) , 1303-6, (2012)
Full Text: HTML
Abstract
Cosmeceuticals represent a marriage between cosmetics and pharmaceuticals. There are numerous cosmeceutically active products which can be broadly classified into the following categories: antioxidants, oligopeptides, growth factors and pigment lightning agents. Much attention has been focused on the tripeptides such as Gly-His-Lys (GHK) and Gly-Gly-His (GGH) and their copper complexes, which have a high activity and good skin tolerance. Recent data suggested their physiological role in process of wound healing, tissue repair and skin inflammation. The mechanism of anti-inflammatory properties of these peptides is not clear. The aim of the study was evaluation of influence of two peptides GGH. GHK and their copper complexes and saccharomyces/copper ferment (Oligolides Copper) on secretion of pro-inflammatory IL-6 in normal human dermal fibroblasts NHDF cell line. IL-6 was evaluated using the ELISA kit. GGH, GHK, CuCl2 and their copper complexes decreased TNF-alpha-dependent IL-6 secretion in fibroblasts. IL-6 is crucial for normal wound healing, skin inflammation and UVB-induced erythema. Because of the anti-inflammatory properties, the copper-peptides could be used on the skin surface instead of corticosteroids or non-steroidal anti-inflammatory drugs, which have more side effects. Our observations provide some new information about the role of these tripeptides in skin inflammation.
Related Compounds
Related Articles:
2015-04-01
[Endocrinology 156(4) , 1540-51, (2015)]
Expression analysis of stemness genes in a rat thyroid cell line FRTL5.
2015-01-01
[Exp. Clin. Endocrinol. Diabetes 123(1) , 48-54, (2015)]
The effect of topical tripeptide-copper complex on healing of ischemic open wounds.
2003-01-01
[Vet. Surg. 32(6) , 515-23, (2003)]
2008-07-15
[J. Pharm. Biomed. Anal. 47(3) , 596-602, (2008)]
2005-01-01
[Arch. Facial Plast. Surg. 7(1) , 27-31, (2005)]